Inactive Instrument

Other languages Novozymes A/S Other OTC

Equities

Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	Apr. 30
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08
China to speed up 'new productive forces', vice president says	Mar. 26
Fed en Argenx helpen Brusselse beurs aan winst	Mar. 24
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21
Novonesis Provides Earnings Guidance for the Year 2024	Mar. 21
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18
Argenx en nieuwkomers zorgen voor rood slot Bel20	Mar. 18
Pas op de plaats voor Bel20 ondanks koerswinst UCB	Mar. 18
Biotalys uitblinker in Brussel	Mar. 18
Brussel start handelsweek vermoedelijk licht hoger	Mar. 18
Biotalys in zee met Novonesis voor Evoca	Mar. 18
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18
FMC Partners With Novonesis in Canada for Biosolution Products	Mar. 12
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	Mar. 07
Novozymes A/S Announces Board Appointments	Mar. 04
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	Feb. 12
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	Feb. 08
Novozymes, Chr. Hansen Complete Merger Settlement	Feb. 02

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 09:18 am EST